Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Stellar Biotechnologies, Inc. (SBOTF) Fully Embracing Social Media as KLH Immunotherapy Really Comes into Its Own

Stellar Biotech is the industry leader in the field of sustainably manufacturable Keyhole Limpet Hemocyanin, or KLH, a revolutionary pharmaceutical protein derived from a scarce species of limpet that only lives in the northeast Pacific, Megathura crenulata, more commonly known as the great or giant keyhole limpet. The exceedingly complex structure and size of the […]

Growblox Sciences, Inc. (GBLX) is “One to Watch”

Growblox Sciences, a biopharmaceutical research and development company, is focused on creating safe, standardized pharmaceutical-grade cannabis-based therapies for various medical conditions. The company is pioneering technology, industry-leading processes, and a big data-driven clinical research and development algorithm to bring relief to patients in communities across the country. The company’s GrowBLOX technology suite includes the TissueBLOX, […]

Cara Therapeutics, Inc. (CARA) Addressing One of the Country’s Biggest Pharmaceutical Niches with Development of Novel Therapeutic

Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain, inflammation and pruritus. The company’s most advanced candidate, CR845, is a patented compound possessing analgesic, anti-inflammatory and anti-pruritic activities that make it appropriate for a variety of therapeutic applications. Currently, the compound is undergoing clinical testing […]

Blue Like Neon Selects IFAN Financial, Inc.’s (IFAN) Payment Gateway to Enhance Customer eCommerce Capabilities

IFAN Financial, a designer, developer, and distributer of software to enable mobile payments, has been selected by Blue Like Neon to provide the digital branding agency with cutting-edge mobile payments solutions. Blue Like Neon utilizes a multi-pronged market enhancement strategy designed to create campaigns that allow clients to better engage with their customers while increasing […]

Galenfeha, Inc. (GLFH) Taps Opportunity in $1B Chemical Injection Market

The International Energy Agency (IEA) today projected that slowing North American oil production will cause non-OPEC supply growth to slow in 2015, though the agency raised its yearly forecasts of non-OPEC oil supply growth by 200,000 p/d to 830,000 p/d compared to last months’ report. According to James Ketner, president and CEO Galenfeha, a manufacturer […]

 

From Our Blog

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Committed to Advancing Cancer Care with Innovative RTNova Platform Research

April 30, 2025

Cancer remains one of the deadliest diseases worldwide. Globally, the World Health Organization reports that the number of deaths will surpass 9.7 million in 2024, with a projected 20 million new cancer cases diagnosed; WHO also noted that it anticipates the cancer burden increasing an estimated 77% by 2050 (https://ibn.fm/VfZlY). These numbers underscore the urgency […]

Rotate your device 90° to view site.